Prognostic Implication of Framingham Risk Score As a Comorbidity Measure on Treatment Outcomes Following First-Line Tyrosine Kinase Inhibitor in Newly Diagnosed CML Patients
May Chiu(University Health Network), Dennis Dong Hwan Kim(University Health Network), María Agustina Perusini(University Health Network), Danielle Pyne(University Health Network), Anthea Travas(University Health Network), Jaeyoon Kim(LG (United States)), Muzaffar Bhatti(University Health Network), Jenny Ho(University Health Network), Amirtha Ambalavanan(University Health Network), Oyeronke Ayansola(Nigeria Centre for Disease Control)
Cited by 0
Related Papers
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2010|1k
Urgent need for a non-discriminatory and non-stigmatizing nomenclature for monkeypox virus
|PLoS Biology|2022|350
Glycolytic Flux Signals to mTOR through Glyceraldehyde-3-Phosphate Dehydrogenase-Mediated Regulation of Rheb
|Molecular and Cellular Biology|2009|189
Lysophosphatidylcholine Activates Adipocyte Glucose Uptake and Lowers Blood Glucose Levels in Murine Models of Diabetes
|Journal of Biological Chemistry|2009|160